According to this latest study, the 2021 growth of Irritable Bowel Syndrome (IBS) will have significant change from previous year. By the most conservative estimates of global Irritable Bowel Syndrome (IBS) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3272.2 million in 2020. Over the next five years the Irritable Bowel Syndrome (IBS) market will register a 7.9% CAGR in terms of revenue, the global market size will reach US$ 4432.8 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome (IBS) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
- IBS-D Drug
- IBS-C Drug
- Other
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
- Women
- Men
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
- Bausch Health
- Allergan
- Takeda
- Sucampo Pharmaceuticals (Mallinckrodt)
- Sebela Pharmaceuticals Inc
- Astellas Pharmaceuticals
Global Irritable Bowel Syndrome (IBS) Market Growth 2021-2026
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Consumption 2016-2026
2.1.2 Irritable Bowel Syndrome (IBS) Consumption CAGR by Region
2.2 Irritable Bowel Syndrome (IBS) Segment by Type
2.2.1 IBS-D Drug
2.2.2 IBS-C Drug
2.2.3 Other
2.3 Irritable Bowel Syndrome (IBS) Sales by Type
2.3.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2021)
2.3.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2016-2021)
2.3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Type (2016-2021)
2.4 Irritable Bowel Syndrome (IBS) Segment by Application
2.4.1 Women
2.4.2 Men
2.5 Irritable Bowel Syndrome (IBS) Sales by Application
2.5.1 Global Irritable Bowel Syndrome (IBS) Sale Market Share by Application (2016-2021)
2.5.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Application (2016-2021)
2.5.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Application (2016-2021)
3 Global Irritable Bowel Syndrome (IBS) by Company
3.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Company
3.1.1 Global Irritable Bowel Syndrome (IBS) Sales by Company (2019-2021)
3.1.2 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2019-2021)
3.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Company
3.2.1 Global Irritable Bowel Syndrome (IBS) Revenue by Company (2019-2021)
3.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2019-2021)
3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Company
3.4 Global Manufacturers Irritable Bowel Syndrome (IBS) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Irritable Bowel Syndrome (IBS) Product Location Distribution
3.4.2 Players Irritable Bowel Syndrome (IBS) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Irritable Bowel Syndrome (IBS) by Region
4.1 Global Irritable Bowel Syndrome (IBS) by Region
4.1.1 Global Irritable Bowel Syndrome (IBS) Sales by Region
4.1.2 Global Irritable Bowel Syndrome (IBS) Revenue by Region
4.2 Americas Irritable Bowel Syndrome (IBS) Sales Growth
4.3 APAC Irritable Bowel Syndrome (IBS) Sales Growth
4.4 Europe Irritable Bowel Syndrome (IBS) Sales Growth
4.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Sales Growth
5 Americas
5.1 Americas Irritable Bowel Syndrome (IBS) Sales by Country
5.1.1 Americas Irritable Bowel Syndrome (IBS) Sales by Country (2016-2021)
5.1.2 Americas Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2021)
5.2 Americas Irritable Bowel Syndrome (IBS) Sales by Type
5.3 Americas Irritable Bowel Syndrome (IBS) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Sales by Region
6.1.1 APAC Irritable Bowel Syndrome (IBS) Sales by Region (2016-2021)
6.1.2 APAC Irritable Bowel Syndrome (IBS) Revenue by Region (2016-2021)
6.2 APAC Irritable Bowel Syndrome (IBS) Sales by Type
6.3 APAC Irritable Bowel Syndrome (IBS) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) by Country
7.1.1 Europe Irritable Bowel Syndrome (IBS) Sales by Country (2016-2021)
7.1.2 Europe Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2021)
7.2 Europe Irritable Bowel Syndrome (IBS) Sales by Type
7.3 Europe Irritable Bowel Syndrome (IBS) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) by Country
8.1.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Sales by Country (2016-2021)
8.1.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2021)
8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Sales by Type
8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Irritable Bowel Syndrome (IBS) Distributors
10.3 Irritable Bowel Syndrome (IBS) Customer
11 Global Irritable Bowel Syndrome (IBS) Market Forecast
11.1 Global Irritable Bowel Syndrome (IBS) Forecast by Region
11.1.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2021-2026)
11.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Irritable Bowel Syndrome (IBS) Forecast by Type
11.7 Global Irritable Bowel Syndrome (IBS) Forecast by Application
12 Key Players Analysis
12.1 Bausch Health
12.1.1 Bausch Health Company Information
12.1.2 Bausch Health Irritable Bowel Syndrome (IBS) Product Offered
12.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Bausch Health Main Business Overview
12.1.5 Bausch Health Latest Developments
12.2 Allergan
12.2.1 Allergan Company Information
12.2.2 Allergan Irritable Bowel Syndrome (IBS) Product Offered
12.2.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Allergan Main Business Overview
12.2.5 Allergan Latest Developments
12.3 Takeda
12.3.1 Takeda Company Information
12.3.2 Takeda Irritable Bowel Syndrome (IBS) Product Offered
12.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Takeda Main Business Overview
12.3.5 Takeda Latest Developments
12.4 Sucampo Pharmaceuticals (Mallinckrodt)
12.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Information
12.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Offered
12.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Main Business Overview
12.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Latest Developments
12.5 Sebela Pharmaceuticals Inc
12.5.1 Sebela Pharmaceuticals Inc Company Information
12.5.2 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Offered
12.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Sebela Pharmaceuticals Inc Main Business Overview
12.5.5 Sebela Pharmaceuticals Inc Latest Developments
12.6 Astellas Pharmaceuticals
12.6.1 Astellas Pharmaceuticals Company Information
12.6.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offered
12.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Astellas Pharmaceuticals Main Business Overview
12.6.5 Astellas Pharmaceuticals Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Irritable Bowel Syndrome (IBS) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of IBS-D Drug
Table 3. Major Players of IBS-C Drug
Table 4. Major Players of Other
Table 5. Global Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 6. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2021)
Table 7. Global Irritable Bowel Syndrome (IBS) Revenue by Type (2016-2021) & ($ million)
Table 8. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2021)
Table 9. Global Irritable Bowel Syndrome (IBS) Sale Price by Type (2016-2021)
Table 10. Global Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 11. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2021)
Table 12. Global Irritable Bowel Syndrome (IBS) Value by Application (2016-2021)
Table 13. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2016-2021)
Table 14. Global Irritable Bowel Syndrome (IBS) Sale Price by Application (2016-2021)
Table 15. Global Irritable Bowel Syndrome (IBS) Sales by Company (2019-2021) & (Million Units)
Table 16. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2019-2021)
Table 17. Global Irritable Bowel Syndrome (IBS) Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2019-2021)
Table 19. Global Irritable Bowel Syndrome (IBS) Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Irritable Bowel Syndrome (IBS) Producing Area Distribution and Sales Area
Table 21. Players Irritable Bowel Syndrome (IBS) Products Offered
Table 22. Irritable Bowel Syndrome (IBS) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Irritable Bowel Syndrome (IBS) Sales by Region (2016-2021) (Million Units)
Table 26. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2016-2021)
Table 27. Global Irritable Bowel Syndrome (IBS) Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2016-2021)
Table 29. Americas Irritable Bowel Syndrome (IBS) Sales by Country (2016-2021) & (Million Units)
Table 30. Americas Irritable Bowel Syndrome (IBS) Sales Market Share by Country (2016-2021)
Table 31. Americas Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Irritable Bowel Syndrome (IBS) Revenue Market Share by Country (2016-2021)
Table 33. Americas Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 34. Americas Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2021)
Table 35. Americas Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 36. Americas Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2021)
Table 37. APAC Irritable Bowel Syndrome (IBS) Sales by Region (2016-2021) & (Million Units)
Table 38. APAC Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2016-2021)
Table 39. APAC Irritable Bowel Syndrome (IBS) Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2016-2021)
Table 41. APAC Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 42. APAC Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2021)
Table 43. APAC Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 44. APAC Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2021)
Table 45. Europe Irritable Bowel Syndrome (IBS) Sales by Country (2016-2021) & (Million Units)
Table 46. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Country (2016-2021)
Table 47. Europe Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Country (2016-2021)
Table 49. Europe Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 50. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2021)
Table 51. Europe Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 52. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales by Country (2016-2021) & (Million Units)
Table 54. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 58. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 60. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Irritable Bowel Syndrome (IBS)
Table 62. Key Application and Potential Industries of Irritable Bowel Syndrome (IBS)
Table 63. Key Challenges of Irritable Bowel Syndrome (IBS)
Table 64. Key Trends of Irritable Bowel Syndrome (IBS)
Table 65. Irritable Bowel Syndrome (IBS) Distributors List
Table 66. Irritable Bowel Syndrome (IBS) Customer List
Table 67. Global Irritable Bowel Syndrome (IBS) Sales Forecast by Region (2021-2026) & (Million Units)
Table 68. Global Irritable Bowel Syndrome (IBS) Consumption Market Forecast by Region
Table 69. Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Irritable Bowel Syndrome (IBS) Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Irritable Bowel Syndrome (IBS) Sales Forecast by Country (2021-2026) & (Million Units)
Table 72. Americas Irritable Bowel Syndrome (IBS) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Irritable Bowel Syndrome (IBS) Sales Forecast by Region (2021-2026) & (Million Units)
Table 74. APAC Irritable Bowel Syndrome (IBS) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Irritable Bowel Syndrome (IBS) Sales Forecast by Country (2021-2026) & (Million Units)
Table 76. Europe Irritable Bowel Syndrome (IBS) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales Forecast by Country (2021-2026) & (Million Units)
Table 78. Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Irritable Bowel Syndrome (IBS) Sales Forecast by Type (2021-2026) & (Million Units)
Table 80. Global Irritable Bowel Syndrome (IBS) Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Irritable Bowel Syndrome (IBS) Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Irritable Bowel Syndrome (IBS) Sales Forecast by Application (2021-2026) & (Million Units)
Table 84. Global Irritable Bowel Syndrome (IBS) Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Irritable Bowel Syndrome (IBS) Revenue Market Share Forecast by Application (2021-2026)
Table 87. Bausch Health Basic Information, Irritable Bowel Syndrome (IBS) Manufacturing Base, Sales Area and Its Competitors
Table 88. Bausch Health Irritable Bowel Syndrome (IBS) Product Offered
Table 89. Bausch Health Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 90. Bausch Health Main Business
Table 91. Bausch Health Latest Developments
Table 92. Allergan Basic Information, Irritable Bowel Syndrome (IBS) Manufacturing Base, Sales Area and Its Competitors
Table 93. Allergan Irritable Bowel Syndrome (IBS) Product Offered
Table 94. Allergan Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 95. Allergan Main Business
Table 96. Allergan Latest Developments
Table 97. Takeda Basic Information, Irritable Bowel Syndrome (IBS) Manufacturing Base, Sales Area and Its Competitors
Table 98. Takeda Irritable Bowel Syndrome (IBS) Product Offered
Table 99. Takeda Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 100. Takeda Main Business
Table 101. Takeda Latest Developments
Table 102. Sucampo Pharmaceuticals (Mallinckrodt) Basic Information, Irritable Bowel Syndrome (IBS) Manufacturing Base, Sales Area and Its Competitors
Table 103. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Offered
Table 104. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 105. Sucampo Pharmaceuticals (Mallinckrodt) Main Business
Table 106. Sucampo Pharmaceuticals (Mallinckrodt) Latest Developments
Table 107. Sebela Pharmaceuticals Inc Basic Information, Irritable Bowel Syndrome (IBS) Manufacturing Base, Sales Area and Its Competitors
Table 108. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Offered
Table 109. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 110. Sebela Pharmaceuticals Inc Main Business
Table 111. Sebela Pharmaceuticals Inc Latest Developments
Table 112. Astellas Pharmaceuticals Basic Information, Irritable Bowel Syndrome (IBS) Manufacturing Base, Sales Area and Its Competitors
Table 113. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Offered
Table 114. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 115. Astellas Pharmaceuticals Main Business
Table 116. Astellas Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Irritable Bowel Syndrome (IBS)
Figure 2. Irritable Bowel Syndrome (IBS) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Irritable Bowel Syndrome (IBS) Sales Growth Rate 2016-2026 (Million Units)
Figure 7. Global Irritable Bowel Syndrome (IBS) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Irritable Bowel Syndrome (IBS) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of IBS-D Drug
Figure 10. Product Picture of IBS-C Drug
Figure 11. Product Picture of Other
Figure 12. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2020
Figure 13. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2021)
Figure 14. Irritable Bowel Syndrome (IBS) Consumed in Women
Figure 15. Global Irritable Bowel Syndrome (IBS) Market: Women (2016-2021) & (Million Units)
Figure 16. Irritable Bowel Syndrome (IBS) Consumed in Men
Figure 17. Global Irritable Bowel Syndrome (IBS) Market: Men (2016-2021) & (Million Units)
Figure 18. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2021)
Figure 19. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application in 2020
Figure 20. Irritable Bowel Syndrome (IBS) Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Company in 2020
Figure 22. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Regions (2016-2021)
Figure 23. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region in 2020
Figure 24. Americas Irritable Bowel Syndrome (IBS) Sales 2016-2021 (Million Units)
Figure 25. Americas Irritable Bowel Syndrome (IBS) Revenue 2016-2021 ($ Millions)
Figure 26. APAC Irritable Bowel Syndrome (IBS) Sales 2016-2021 (Million Units)
Figure 27. APAC Irritable Bowel Syndrome (IBS) Revenue 2016-2021 ($ Millions)
Figure 28. Europe Irritable Bowel Syndrome (IBS) Sales 2016-2021 (Million Units)
Figure 29. Europe Irritable Bowel Syndrome (IBS) Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales 2016-2021 (Million Units)
Figure 31. Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue 2016-2021 ($ Millions)
Figure 32. Americas Irritable Bowel Syndrome (IBS) Sales Market Share by Country in 2020
Figure 33. Americas Irritable Bowel Syndrome (IBS) Revenue Market Share by Country in 2020
Figure 34. Americas Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2020
Figure 35. Americas Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2020
Figure 36. United States Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Irritable Bowel Syndrome (IBS) Sales Market Share by Region in 2020
Figure 41. APAC Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions in 2020
Figure 42. APAC Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2020
Figure 43. APAC Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2020
Figure 44. China Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Country in 2020
Figure 51. Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Country in 2020
Figure 52. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2020
Figure 53. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2020
Figure 54. Germany Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2020
Figure 63. Egypt Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Irritable Bowel Syndrome (IBS) Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 110
According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period.
The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......
Global Lansoprazole Market Research Report 2024
Published: 04-Jan-2024 Price: US 2900 Onwards Pages: 102
The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the comp......
Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 88
According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period.
The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......
Global Esomeprazole Market Research Report 2024
Published: 04-Jan-2024 Price: US 2900 Onwards Pages: 89
The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the comp......
Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 02-Jan-2024 Price: US 3380 Onwards Pages: 126
Market Overview of Global Irritable Bowel Syndrome (IBS) market:
According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......
Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Dec-2023 Price: US 3380 Onwards Pages: 109
Market Overview of Global Diarrhea Drug market:
According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......
Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024
Published: 27-Dec-2023 Price: US 3350 Onwards Pages: 96
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......
Global Lansoprazole Professional Survey Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 3280 Onwards Pages: 136
Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......
Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 113
Market Overview of Global Pentasa (Ulcerative Colitis) market:
According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
